Buprenorphine use remained stable during first year of pandemic

Close Up Scientist using microscope in laboratory room while making medical testing and research

The number of active prescriptions for the opioid disorder treatment drug buprenorphine remained constant during the first year of the COVID-19 pandemic, but the number of new prescriptions for the treatment was far below what would normally have been expected, according to a new RAND Corporation study.

Salton Sea dust triggers lung inflammation, shows research

Previous article

Adults’ interactions at mealtimes influence children’s future relationships with food

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations